Home / HealthHealthStraits TimesHealthStraits Times·Jul 15, 2026·1 min readStudy flags need to monitor frailty risks with GLP-1 drugs for older adultsExperts say the study findings do not show that the GLP-1 obesity drug Zepbound causes adverse outcomes.View original source — Straits Times ↗ShareCopy linkShare on XShare on FacebookRelated storiesHealthTimes of IndiaHealthSep 19, 2026 · 1 min17-year-old cancer survivor Ethan Huynh raises $45,000 for kidsTimes of IndiaHealthFrance 24HealthSep 19, 2026 · 1 min37 die in Nigerian custody: Reports blame overcrowding, government disputes claimFrance 24HealthNPRHealthSep 19, 2026 · 1 minAncient teeth pose a mystery: What made those strange grooves?NPRHealthBuenos Aires TimesHealthSep 19, 2026 · 1 minHistorically high suicide rates cause alarm in ArgentinaBuenos Aires Times
HealthTimes of IndiaHealthSep 19, 2026 · 1 min17-year-old cancer survivor Ethan Huynh raises $45,000 for kidsTimes of India
HealthFrance 24HealthSep 19, 2026 · 1 min37 die in Nigerian custody: Reports blame overcrowding, government disputes claimFrance 24
HealthBuenos Aires TimesHealthSep 19, 2026 · 1 minHistorically high suicide rates cause alarm in ArgentinaBuenos Aires Times